© 2020 MJH Life Sciences and Urology Times. All rights reserved.
© 2020 MJH Life Sciences™ and Urology Times. All rights reserved.
December 05, 2020
Clinical activity with MK-6482 was observed in both RCC and non-RCC lesions.
December 04, 2020
The algorithm was applied to 50 patients who underwent radical prostatectomy between 2008 and 2018.
Ten-year data showed high overall survival and recurrence-free survival rates with Mohs surgery in patients with localized penile cancer.
The app also provides patients with a socially distant alternative to in-person visits during the COVID-19 pandemic.
Cancer-specific survival is noninferior for active surveillance compared with primary intervention in select patients with small renal masses suspicious for renal cell carcinoma.
Blue light cystoscopy identified patients with bladder cancer recurrence post-BCG that would have been missed with standard white light cystoscopy alone.
December 03, 2020
A separate analysis presented at SUO assessed the impact of nadofaragene firadenovec on the incidence and time to cystectomy.
Arjun V. Balar, MD, walks through the patient discussion when weighing the use of pembrolizumab (Keytruda).
Of 13 studies evaluated by investigators for the meta-analysis, only 1 was a randomized controlled trial.
Physicians involved in clinical trials should have the patient in mind “from the very conception of the design to the conduct of the study to dissemination of the results,” says Angela B. Smith, MD, MS.